| Literature DB >> 34532523 |
Jonas Mechtersheimer1, Stefan Reber1, Marc-David Ruepp1.
Abstract
This protocol describes the application of the CRISPR-Trap from designing of the gene targeting strategy to validation of successfully edited clones that was validated on various human cell lines, among them human induced pluripotent stem cells (hiPSCs). The advantage of CRISPR-Trap over conventional approaches is the complete removal of any endogenous full-length transcript from the target gene. CRISPR-Trap is applicable for any target gene with no or little coding sequence in its first exon. Several human cell lines and different genes have so far been edited successfully with CRISPR-Trap.Entities:
Keywords: CRISPR; CRISPR-Trap; Gene editing; Gene knockout; Gene replacement; hiPSCs
Year: 2018 PMID: 34532523 PMCID: PMC8342058 DOI: 10.21769/BioProtoc.3052
Source DB: PubMed Journal: Bio Protoc ISSN: 2331-8325